Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers & Combinations with PARP Inhibitors, PD-1 Inhibitors, and Anti-angiogenic Agents
Login to view comments.
Click here to Login
Updates in Oncology